Elite Perfusion SRL
Elite Perfusion reported total assets of 858,194 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of Elite Perfusion shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +177 % Total assets +173 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Elite Perfusion's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 129,151 € | ||||
| Equity | 669,834 € | ||||
| Cash | 168,042 € | ||||
| EBITDA | 213,708 € | ||||
| Total assets | 858,194 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 26 Jun 2025
- Year ended 31 Dec 2023filed on 25 Jun 2024
- Year ended 31 Dec 2022filed on 20 Jun 2023
- Year ended 31 Dec 2021filed on 07 Jul 2022
Elite Perfusion's financial analysis
- Solvency78.1%sector median: 62.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Elite Perfusion
Elite Perfusion's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0734.439.161
- VAT number
- BE0734439161
- Peppol
- Registered · 0208:0734439161 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Sep 2019
- Registered office
- 4261 Braives
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Nursing and midwifery activities (NACE 86940)
Elite Perfusion (SRL) has been based in Braives since 2019, active in: nursing and midwifery activities. For 2025, it reports a net profit of 129,151 € and equity of 669,834 €; its revenue is not published. Its solvency stands at 78.1%, above the median of its sector (62.4%).
Companies similar to Elite Perfusion
Companies in the same business, of comparable size and area, outside its group.
- Avinci Computer programming activities Ghent · balance sheet 858,280 €
- Immobilière de Lèvremont Waterloo · balance sheet 857,907 €
- C.V.L. Binding and related services Saint-Gilles · balance sheet 857,787 €
- Lanimo Kortrijk · balance sheet 857,517 €
- Rust Invest Sea and coastal passenger water transport Herentals · balance sheet 859,024 €
- DR. Roelands Patrick Zemst · balance sheet 858,093 €
- Cabinet de radiologie LESUR Guy Wanze · balance sheet 858,589 €
- Docteur Laurent LAHAYE Berloz · balance sheet 857,704 €
Frequently asked questions about Elite Perfusion
What is the revenue of Elite Perfusion?
Elite Perfusion files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Elite Perfusion?
In Belgium, the VAT number is the company number prefixed with BE: BE0734439161 for Elite Perfusion, if the company is VAT-registered. Its company number (CBE) is 0734.439.161.
Where is the registered office of Elite Perfusion?
According to the CBE register, the registered office of Elite Perfusion is in 4261 Braives.
What is the equity of Elite Perfusion?
At the close of the 2025 financial year, the equity of Elite Perfusion amounts to 669,834 €, a solvency of 78.1% of total assets.
Who manages Elite Perfusion?
The register lists 1 active mandates at Elite Perfusion. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Elite Perfusion
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →